2003
DOI: 10.1159/000075173
|View full text |Cite
|
Sign up to set email alerts
|

Use of the NeuroMate Stereotactic Robot in a Frameless Mode for Movement Disorder Surgery

Abstract: Background/Aims: To evaluate the use of the NeuroMate stereotactic robot with a novel ultrasound registration system for movement disorder surgery (MDS). Methods: Using the robot in a frameless mode, 51 patients underwent MDS. Surgical planning was carried out using MRI data obtained more than 24 h before surgery. Results: 37 out of 50 targets in the subthalamic nucleus were satisfactorily identified with a single microelectrode trajectory and the final electrode positions were at a mean distance of 1.7 mm fro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
27
0
1

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(29 citation statements)
references
References 6 publications
1
27
0
1
Order By: Relevance
“…However, it can also be used with a unique frameless ultrasound registration system. We have previously described the use of the robot in a frameless mode for movement disorder surgery (4) and in this paper we describe the preclinical evaluation of the application accuracy of the system, followed by a review of our experience of its use in functional neurosurgery.…”
Section: Introductionmentioning
confidence: 99%
“…However, it can also be used with a unique frameless ultrasound registration system. We have previously described the use of the robot in a frameless mode for movement disorder surgery (4) and in this paper we describe the preclinical evaluation of the application accuracy of the system, followed by a review of our experience of its use in functional neurosurgery.…”
Section: Introductionmentioning
confidence: 99%
“…The Evolution I robot was developed for endoscopic applications, and used in 2002 for the transphenoidal removal of pituitary adenoma [ 29 ]. The CT-based NeuroMate system became the fi rst neurosurgical robot to receive FDA approval for clinical use [ 30 ]. The Pathfi nder system followed in 2006, with highly accurate CT-guided stereotactic application [ 31 ].…”
Section: Neurosurgical Roboticsmentioning
confidence: 99%
“…The tool actuator, mounted on a NeuroMate robotic system [9], is equipped with a DC mini-motor which drives a miniature ball screw through a synchronous belt with a load cell that measures contact forces within the brain tissue. The NeuroArm system, which is magnetic resonance compatible, features ultrasonic piezoelectric motors [10] and titanium multi-axis force/torque sensors on the end effector to provide three Degrees of Freedom (DoFs) force feedback, thus providing high-fidelity haptic feedback to the hand controllers.…”
Section: Introductionmentioning
confidence: 99%